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SUMMARY 
The effect of hemicholinium-3 on the incorporation of [Me-%]choline into the 
phospholipids of the subcellular fractions of the canine caudate nucleus was studied. 
A correlation between the amount of hemicholinium-3 administered and increased 
choline incorporation into phospholipids was obtained. The analysis of the labeled 
phospholipids revealed that 93% of the radioactivity was in phosphatidylcholine and 
the remainder in lysophosphatidyl choline and sphingomyelin + choline plasmalo- 
gens. The specific radioactivity of phosphatidylcholine (countslmin per ,ug phosphorus) 
determined after its isolation by thin-layer chromatography, increased markedly as a 
result of the administration of hemicholinium. An unequal time-dependence in the 
labeling of the phosphatidylcholine in the subcellular fraction containing nerve en- 
dings, mitochondria and lysosomes, as opposed to the phosphatidylcholine of the 
microsomal fraction was also noted, particularly after the administration of hemi- 
cholinium and choline in a weight ratio of 500. 
Discontinuous density gradient centrifugation of the fraction containing the nerve 
endings, the mitochondria and the lysosomes showed that phosphatidylcholine forma- 
tion was most affected by hemicholinium in the fraction containing the “heavy” 
nerve endings, followed by the fraction containing the mitochondria + lysosomes. 
It is suggested that hemicholinium acts by accelerating the intracellular rate of 
movement of choline from the water-soluble into the lipid pool of the caudate nucleus 
where, by virtue of its presencelQ, it subsequently also stimulates the incorporation 
of choline into membrane phosphatidylcholine. 
INTRODUCTION 
In spite of the essential nature of choline as an obligatory precursor of acetylcho- 
line, a neurotransmitter substance in brainlpa, and of phosphatidylcholine, a ubiqui- 
tous component of cerebral membranes ss4 the metabolism of this substance in brain 
* A preliminary report has been presented (Federation Proc., 28 (1969) 292). 
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tissue has not been studied extensively. Knowledge of the details governing its meta- 
bolic disposition in the various neuroanatomical regions of the brain is most desirable, 
especially since it may turn out that its metabolic fate is geared to the functional 
competence of a given brain region. The synthesis of choline by successive methyla- 
tions of ethanolamine, a biosynthetic pathway in extracerebral tissues6 appears not 
to be quantitatively significant in brain 6. Choline must be supplied preformed from 
the liver?. The question of its uptake by brain tissue is therefore particularly relevant. 
A previous report dealing with the intracellular disposition of chohne in the canine 
caudate nucleus addressed itself to this issue”. Tvt’ith regard to its further metabolism, 
it is known that phosphorylcholine9~10 and phosphatidylcholine7Jo are its major meta- 
bolites, while acetylcholine is a minor one 11-13. 
Hemicholinium-3 (ref. 14) the bishemiacetal form of a,a-dimethylethanolamino-4,4’- 
bisacetophenone, is a pharmacologic agent frequently used in studies of the uptake of 
choline and of its further conversion to acet~~lcholine in l~embrane-enclosed systems, 
It has been known for some time 11$15y16 that this drug may decrease the uptake of 
choline by such systems, and hence influence the formation of acetylcholine necessary 
for maintenance of normal tissue levels10s17J8. 
Recently, we have examined the dynamics of the cellular uptake, the intracellular 
movement and the intracellular localization of [**C]hemicholinium in the caudate 
nucleus of the dogI%, a region in which ac~tylcl~oline levels are greatly reduced follow- 
ing its intraventricular administration. We noted that, 4 h after its adininistration, 
jlK]hemicholinium was tightly bound to the intracellular membranes of the caudate. 
Also in a previous paper*, we reported that the proportion of the injected choline 
appearing as radioactive phosphorylcholine and cytidine diphosphocholine was ap- 
preciably increased if ~lemicholinium was administered with choline. The present 
paper describes the subsequent steps of cytidine diphosphocholine utilization in the 
caudate nucleus of the dog; namely its conversion to phospllatidylclloline. The partic- 
ularly novel aspect of the present study, documented in detail below, is the observed 
acceleration of the conversion of choline to phosphatidylcholine by hemicholinium. 
MATERIALS 
A&m&. Mongrel, beagle-like dogs were useds. 
Chemicals. The following were used: silica G-25 (Merck and Co.) silicic acid (UNISIL, 
Clarkson Chem. Co., Williamsport, Pa.), Biosolv-3 (Beckman Co., Fullerton, Calif.) 
and [r,z-lK]phosphatidylcholine chloride (Tracerlab, Lot No. 867-165-8), specific 
activity: 75.4 mC/mmole. ~~~e-l*C~choline chloride 7.6 mC/mmole (New England 
Nuclear) and 54 nlC~l~l]~~ole (Amersham-Searle) were used. 
METHODS 
A~&zals. The surgical procedure as well as the intraventricular injection and sacri- 
fice techniques were described previously8119. 
C~nty~~zt.g~t~o~. Caudate homogenates were subjected to differential and density 
gradient centrifugation as described in a previous communication19. The particulate 
fraction sedimenting at IOOOO x g contained myelin, nerve endings, mitochondria 
and lysosomes. It is termed the heavy particulate fraction. The microsomal fraction 
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sedimented at IOOOOOX~ after a r-h centrifugation. The procedure was modeled 
after that of DE ROBERTIS et aLzO. 
Separation of the water-soluble metabolites from tissue lipids. The water-soluble 
components, choline, acetylcholine, phosphorylcholine and cytidine diphosphocholine 
were extracted by the procedure of CROSSLAND AND MERRICK~~. Most of the lipids were 
first extracted into ethe? and two chloroform-methanol (z:I, v/v) washes of the 
aqueous phase were combined with the ether extract. The total lipids thus obtained 
were subjected to silicic acid chromatography (Unisil) for separation into neutral and 
phospholipids. The latter fraction was counted directly or was separated into several 
components by thin-layer chromatography. 
Thin-layer chromatography of phospholipids. This was done on silica G-25 using a 
mixture of chloroform-methanol-water (65 : 25 : 4, by vol.) as solventz2. While choline 
plasmalogens and phosphatidylcholine are not separated, a good separation of sphin- 
gomyelin, lysophosphatidyl- and phosphatidylcholine is achieved. Authentic [Xl- 
phosphatidylcholine was used as marker. The dry plates were exposed to iodine vapors 
for visualization of the spots. 
Chemical hydrolysis of phospholipids. The hydrolytic method of DAWSON et al.23 
was used for the identification of and the assignment of the radioactivity among 
choline plasmalogens, sphingomyelin and phosphatidylcholine. 
Analytical. The method of BARTLETT~~ was used for the determination of total 
phosphorus. When phosphorus was determined on scrapings of silica G-25 removed 
from thin-layer chromatography plates, a standard sample was applied to a blank 
region of the plate after chromatographic development and was then processed as the 
experimental phospholipid spots. The values obtained for that standard were identi- 
cal to those given by a sample analyzed directly. 
Radioactivity. The radioactivity was determined by liquid scintillation techniques. 
Samples were prepared for counting in scintillation vials by evaporation of all sol- 
vents at which time 15 ml of a counting fluid of the following composition were added : 
I 1 of dioxane, 8 g of z,5-diphenyloxazole, 0.1 g of r,4-bis-(5-phenyloxazolyl-z) ben- 
zene and IIO g of naphthalene. Appropriate quenching corrections were applied and 
the counts/min were converted to disint./min using a suitable program on the PDF-8 
computer. The counting efficiency of the spectrometers used ranged between 80 and 
90%. Radioactivity derived from scrapings of thin-layer chromatography plates was 
determined as described previouslys, except that bleaching of the iodine color was 
done in an oven (100’ for IO min). 
RESULTS 
The effect of the hemicholiniumlcholine ratio 0% the conversion of [Me-14C]choline to 
phospholifiids 
The partition of radioactivity 4 h after the administration of choline between the 
water-soluble choline metabolites and the cholinephospholipids in the heavy particulate 
and the microsomal fractions is shown in the first set of bars of Fig. I (hemicholinium/ 
choline = 0). In the heavy particulate fraction about 80% of the radioactivity was 
in the phospholipids as against only 40% in the microsomal fraction. The correspond- 
ing r-h values (not shown graphically) were 62% for the heavy particulate and 55% 
for the microsomal fraction. When hemicholinium and [Ille-14C]choline were ad- 
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ministered together in varying ratios and the phospholipid radioactivity again exa- 
mined 4 h later, the percentage in the heavy particulate fraction increased to about 
9076 (hemicholinium/choline = LOO), with intermediate values for intermediate hemi- 
cholinium/choline ratios (IO and 100). The increase in the microsomal fraction was 
0 
0 IO 100 500 
Hemicholinium/[~e-l~~choline ratio 
Fig. I. The effect of hemicholinium on the distribution of [Me-r4C]choline radioactivity between 
the water-soluble and the phospholipid extracts of the heavy particulate (A) and the microsomal 
(B) fractions of the dog caudate nucleus. The dose of [Me-r%]choline was ro pg (0.73 mC). 
Unlabeled hemicholinium was administered jointly at doses of o (three animals), roe (two animals), 
IOOO (two animals) and 5000 pg (two animals). After isolation, they were lyophilized and the resi- 
dues extracted2r. The lipid extract was further separated into its neutral and phosphorylated 
components (see METHODS) before determination of the radioactivity. The height of the bars 
indicates mean percent values. 
from 37 to 90% for a hemicholinium/choline ratio of 500. At I h post-administration 
no significant changes in phospholipid radioactivity as a function of the hemicholi- 
nium/choline ratio could be detected. Also, at no time were the neutral lipids labeled. 
The effect of hemicholiniunz on the time-course of [Me-W]choline incor$oration into 
phospholi$is 
Although an obvious effect of hemicholinium on phospholipid labeling in the heavy 
particulate and the microsomal fractions could not be detected I h after the adminis- 
tration of [Me-14C]choline, it was possible to see increases in the specific activity 
(disint. /min per pg phosphorus) of the labeled phospholipids as early as 15 min after 
the simultaneous administration of hemicholinium and choline. The results (Figs. z 
and 3) show that the specific radioactivity of phospholipids in both fractions was 
markedly elevated over that of the controls receiving no hemicholinium and that, 
irrespective of the hemicholinium/choline ratio (Fig. 2) or of the time of administra- 
tion (Fig. 3), it was higher in the microsomal than in the heavy particulate fraction 
(by about 300% in the former fraction at 4 h and with a hemicholinium/choline ratio 
of 500 (Fig. 3)). Yet, as shown in Fig. 4, when the specific radioactivity of the phospho- 
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lipids in the hemicholinium-treated fractions was divided by that of the controls, the 
response to the drug of the two fractions revealed time-dependent individual differen- 
ces, Thus, while the magnitude of the hemicholinium effect on the phospholipids of 
the heavy particulate fraction reached a maximum at I h and then abated, the effect 
of hemicholinium on the specific activity of the phospholipids of the microsomal frac- 
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Fig. 2. The effect of hemicholinium on the specific radioactivity of the phospholipid extract of the 
heavy particulate and the microsomal fractions at I and 4 h after the administration of [Me-r%]- 
choline. For the isolation of the heavy particulate fraction (A) and the microsomal fraction (B), see 
METHODS. The phospholipid extract was obtained and its radioactivity and phosphorus content 
determined as outlined in METHODS. 
Fig. 3. The time-course of the hemicholinium effect on the specific radioactivity of the phospho- 
lipids of the heavy particulate ( l ) and the microsomal ( 0) fraction. The hemicholinium/ [Me-r%]- 
choline ratio was =joo (see legend Fig. I). The high-specific-activity [Me-Wlcholine (54 mC/mmole) 
was used for the rg-min time point while, for the I- and 4-h time points, the low-specific-activity 
[Me-Wlcholine (7.6 mC/mmole) was injected. 
The isolation of $hos@hatidylcholine 
Thin-layer chromatography of the phospholipid extracts of both particulate frac- 
tions (see METHODS) followed by the determination of the radioactivity in the resolved 
phosphatidylcholine (f choline plasmalogen), lysophosphatidyl choline and sphin- 
gomyelin revealed that 93% of the radioactivity was in the phosphatidylcholine spot 
with the remaining 7% divided between sphingomyelin (4%) and lysophosphatidyl 
choline (3%). These results were verified independently by subjecting a phospholipid 
extract to alkaline hydrolysiP as a result of which it became possible to assign 93.9% 
of the radioactivity to the combination phosphatidyl- + lysophosphatidyl choline, 
2% to choline plasmalogens and 4% to sphingomyelin. 
The e$ect of the hemicholiniumlcholine ratio on the speci$c activity of phosphatidylcholine 
The specific activity of phosphatidylchohneisolated from thin-layer chromatogra- 
phic plates was determined at I and 4 h after the administration of hemicholinium and 
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Fig. 4. The ratio of the specific activities of phospholipids extracted from the heavy particulate 
(0) and the microsomal (0) fractions 15, 60 and 240 min after hemicholinium + [Me-WZ]choline 
vs. [Me-YJehofine alone. For experimental details and the definition of the fractions see legends 
to Figs. I and 3 and text (METHODS). 
Fig. j. Effect of hemicholinium on the specific radioactivity of phosphatidylcholine in the heavy 
particulate ( 0) and the microsomal ( l ) fractions. Phosphatidylcholine was isolated from the thin- 
layer chromato~aphic plates and its phosphorus content and radioactivity were determined (see 
METHODS). The former analysis was performed in duplicate on two samples which were chromato- 
graphed side by side. The upper panel refers to I h and the lower panel to 4 h after the administra- 
tion of [.cle-W]choline and hemicho~inium~ For the definition of the abscissa (note log values), 
see the legend to Fig. I. See METHODS for the isolation of the heavy particulate and the microsomal 
fraction. 
[~e-l~c~choline in ratios of IO, 100 and 500. As illustrated in Fig. 5, hemicholinium 
caused its increase both at I and 4 h and which was more pronounced in the microso- 
ma1 fraction than in the heavy particulate fraction. 
The e$ect of hevnicholinizcm on membrane @hos$hatidylcholi~e 
Since the results of the experiments depicted in Figs. 2 and 4 clearly indicated that 
phosphatidy~c~o~ne was the main phospholipid affected by hemicholinium and since, 
on the other hand, phosphatidylcholine is an essential constituent of myeiin, and of 
the membranes of mitochondria and nerve endings 38 these intracellular components 
wereisolated by density gradient centrifugation of the heavy particulate fraction1gp26 
and the specific radioactivity of the extracted phospholipid (phosphatidylcholine) 
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TABLE I 
THE SPECIFIC RADIOACTIVITY OF THE PHOSPHOLIPIDS IN SUBFRACTIONS OF THE HEAVY PARTICULATE 
FRACTION OF THE DOG CAUDATE NUCLEUS 
5 mg of hemicholinium and IO pg of [Me-Wlcholine (specific activity: 54 mC/mmole) were ad- 
ministered jointly or only [Me-K]choline was administered and the animals were killed 4 h later. 
The heavy particulate subfractions were isolated by the procedure of DE ROBERTIS et aZ.25. They 
contain: A, myelin; B, synaptic debris and myelin; C, nerve endings; D, nerve endings, mitochon- 
dria and lysosomes; and E, free mitochondria. The numbers in parentheses refer to the molarity 
of sucrose separating a given fraction from the one below. P, pellet. The phospholipids were ex- 
tracted from the fractions isolated as bands after their sedimentation at 104000 x g for 3 h and 
suspension of the resulting pellets in water. Fraction P, suspended in 0.25 M sucrose, was also 
subjected to resedimentation, as above. 
- 
Subfraction After After Effect of 
[Me-‘“Clcholine [Me-%]choline hemicholinium 
(disint./min per f hemicholinium (%) 
pg phosphorus) (disint./min per 
pg phosphorus) 
A (0.8) r60 206 +2S 
B (0.1) 222 257 t-15 
c (1.2) 281 341 +21 
D (1.4) 451 759 +68 
E P) 705 1063 +50 
DISCUSSION 
While the intraventricular administration of hemicholinium is known to result in a 
marked reduction of cerebral acetylcholine levels 8,11v17, its use in experiments with 
cerebral tissue slices has demonstratated its ability to block the influx of choline2’p28 
and hence, by virtue of a secondary effect, the synthesis of acetylcholine. Recently, 
the incorporation of uniformly labeled [‘“Clglucose (into the acetyl moiety) and of 
[Me-%]choline (into the choline moiety) of acetylcholine has been shown to be marked- 
ly and equally inhibited by 0.1 mM hemicholiniumZ8. The uptake of choline by isolated 
nerve endings is affected equally severely12g13. 
From the bulk of the metabolic studies it would seem, therefore, that the primary 
metabolic action of hemicholinium is to block the transport of choline across biological 
membranes. Yet, perhaps because of an overtly unitary approach to the study of its 
mode of action, other aspects of its biochemical action spectrum appear to have been 
neglected. 
In a recent papers, we have reported an effect of hemicholinium on the distribution 
of [Me-Xlcholine radioactivity among the subcellular fractions of the dog caudate 
nucleus. Previouslyl@, we also reported the time constants of [14C]hemicholinium 
entry into, and its subsequent movement through this tissue. The conclusions drawn 
from both of these studies8+’ were that hemicholinium most probably acts to accelera- 
te the movement of [Me-%]choline from the soluble into the structured portions of the 
caudate cells (nerve endings, mitochondria, myelin, etc.). Of particular significance in 
this regard was the finding that such an acceleration of the choline flux through the 
cell occurred in synchrony with the movement of hemicholinium, for the effect of the 
drug on the mobilization of choline was maximal at 4 h after the latter’s administra- 
tion which is also the timeI of maximal accumulation of hemicholinium in the cauda- 
te subcellular membranes. 
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The effect of hemicholinium on the conversion of [Me-r%]choline to cytidine 
diphosphocholine was shown to be highest at a drug/choline ratio of 500 (ref. 8). 
The subsequent fate of cytidine diphospllocholine, namely its conversion to phosphati- 
dylcholine and the concomitant shift of the radioactivity from the water-soluble to 
the lipid phase was also highest under these conditions, as depicted by the bar graphs 
in Fig. 2. Calculation reveals that at 4 h post-administration, 35-45% more radio- 
activity was present as phosphatidylcholine in the heavy particulate and the microso- 
ma1 fractions of the lle~nicholinium-treated animals that in corresponding controls; 
interestingly at I h post-administration, the net effect of hemicholinium on this 
conversion was a mere 6-W/& Recently, the effect of hemicholinium on phospholipid 
formation from choline has been investigated by COLLIER AND LANG'O, who perfused 
the superior cervical ganglion of the cat with [Me-3H]choline and showed that, after 
I h of perfusion, the radioactivity which could be extracted from the ganglion in lipid 
form was about one fourth of that present in water-soluble form; llemicholiniur~l added 
to the perfusion fluid at a concentration of IO pg/ml failed to change this proportion. 
These results are compatible with our 1-h results, inasmuch as they also emphasize 
the necessity of longer exposures of membrane systems to hemicholinium if the latter’s 
effects on lipid accumulation are to be demonstrated. When, however, the specific 
activity of the phospholipids was examined, immediate effects of the drug on the rate 
of ~~~~-l~C~choline incorporation into phosphatidylcholine became apparent. Thus, 
at I h, the specific activity of the control heavy particulate and microsomal fractions 
was 5 and 14 counts/min per ,~g phosphorus, while after hemicholinium + choline 
(ratio 500) these values were 25 and 45 counts/min per ,ug phosphorus, respectively, 
representing a 5- and a 3-fold increase over controls. At 4 h, the increases were 2.3- 
fold for the heavy particulate fraction and 4.r-fold for the microsomal fraction (Fig. 2). 
These results as well as those depicted in Fig. 3 and which include the rj-min time 
point, reveal that the formation of phospholipid in the two subcellular fractions was 
unequally affected by hemicholinium. In the microsomal fraction the effect of hemi- 
cholinium was sustained through the period 1-4 h, resulting in a net rise of the ratio 
of specific activities: hemicholinium/control (ordinate, Fig. 4) from 2.7 to 3.3 while in 
the heavy particulate fraction this ratio decreased from 3*8 to 2. Interestingly, during 
the first hour after hemicholinium administration, the effect of the drug on [ille-l*C]- 
choline incorporation into phosphatidylcholine was more intense in the heavy particu- 
late than in the microsomal fraction. It should be noted, however, that these differen- 
ces in the incorporation of choline into the phospholipids of these two fractions were 
probably a reflection of the high hemicholinium/choline ratio (500) used, for, as shown 
by inspection of Fig. 5 and by suitable calculation of the specific activity ratios, they 
were not seen with helnicl~olinium~choline ratios of IO and IOO. 
To test whether the drug effect related specifically to choline, the incorporation 
of [I,~-l%]ethanolamine into the phosphatidylethanolamine of the heavy particula- 
te and microsomal fractions was investigated. A marked increase in specific radioac- 
tivity was noted in the microsomal fraction (from a value of 58 in the controls to 135 
in the hemicholinium-treated caudates) but not in the heavy particulate fraction 
(from a value of 50 in the controls to 59 in the hemicholinium-treated caudates). Since 
only 4-h experiments with a hemicholinium/choline ratio of 500 have been carried out 
to date, conclusions regarding an effect of the drug on phospholipid formation in 
general, while attractive, may admittedly be somewhat premature. 
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The combined results of this and a previous papers confirm the existence in the 
canine caudate nucleus, of the pathway of choline metabolism found to be dominant 
in rat brain7. This pathway involves the initial phosphorylation of choline followed by 
the formation of cytidine diphosphocholine and the subsequent transfer of the phos- 
phorylcholine to a diglyceride. MCCAMAN AND COOKIE have recently investigated the 
intracellular localization in rat brain of the enzymes catalyzing the first and the last 
step of the above sequence, namely choline phosphokinase and phosphocholine- 
diglyceride transferase, and have concluded that the activity of the former is mostly 
in the soluble phase of the cell, while the latter shares a largely microsomal + “mito- 
chondrial” localization. Further analysisZ9 revealed that areas of the brain possessing 
a high neuronal density, such as the caudate nucleus, are particularly rich in both 
enzymes. 
Our results on the presence of choline-derived radioactivity in membranes other 
than the microsomal contrast with the recent observations of NAGLEY AND HALLINAN~O 
who noted that, in liver, choline is an exclusive marker of the microsomal phosphati- 
dylcholine. The different experimental conditions and the different tissues used most 
probably account for our finding a large proportion of the phosphatidylcholine radio- 
activity in the phosphatidylcholine of the membranes of nerve endings, mitochondria 
as well as in myelin (Table I). Our results are in substantial agreement, however, 
with the findings of PLAGEMANN~~, who observed choline incorporation into the nuc- 
lear, mitochondrial, plasma and microsomal membrane phosphatidylcholine of rat 
hepatoma cells grown in culture, as well as with the findings in vitro of KAISER~~, 
who has recently described a phosphatidylcholine-synthesizing system in liver mito- 
chondria. 
The relation of a few drugs to cerebral phospholipid formation has recently been 
reviewed by ANSELL AND HAWTHORNE” and ANSELL~~Y~~. Subsequently, acetylcholine 
has been shown to inhibit the incorporation of 32P into the phospholipids of nerve 
ending membranes of rat brain3B and tetraphenylborate has been found to stimulate 
phospholipid labeling in goldfish brain . 37 With regard to effects of hemicholinium, in 
addition to the observations of COLLIER AND LANGIO discussed above, the only other 
report concerns the “significant” decrease of phosphatidylcholine noted in extracts 
of Ehrlich ascites tumors isolated from mice receiving hemicholinium38. Since those 
studies did not include measurements of isotope incorporation rates, they cannot be 
compared to the present results. 
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